'Jackpot': Release date, plot and all you need to know about Sony Pictures's Spider-Mom movie
We have got another web-slinger coming our way, after Peter Parker and of course, Miles Morales. Back in 2018, emboldened by the success of 'Into The Spiderverse' and Tom Holland's Spider-Man entry into the Marvel Cinematic Universe, Sony had announced that it was developing 'Jackpot'. The project is speeding up and according to Deadline, it will be written by comic book writer, screenwriter and TV producer Marc Guggenheim. The focus will be on a scientist-turned hero, who appeared in May 2007 as part of Spider-Man: Swing Shift, a Free Comic Book Day issue written by Dan Slott with art by Phil Jimenez. While many women characters have taken up the mantle of Jackpot. The first was Sarah Ehret, a scientist, with a focus on gene therapy. A pregnant Ehret is exposed to Lot 777, a virus that re-writes her cells. While it has no effect on her daughter, who is born healthy, Ehret develops superpowers. Here's all we know about the film.
The Oscar win for 'Spider-Man: Into The Spider-Verse' and Tom Holland's Spider-Man boosted Sony's morale. The next set of projects for Sony include 'Venom: Let There Be Carnage' and Jared Leto's 'Morbius', who is Spidey's ally. Due to the coronavirus pandemic, these films have had to be pushed back, meaning that we won't see Jackpot probably till 2022-23, if we are being very hopeful. For starters, Guggenheim is the only person attached to the project as of now and nothing else has been decided.
Jackpot's storyline oscillates between her life as a superhero and a mother and this makes her a compelling addition to the Spider-Verse. Sara is exposed to Lot 777 and goes into coma for four months. When she wakes up, she realizes that she has superhero human strength. After she gives birth, she joins a government-sanctioned superhero initiative, but despite her powers, she is not interested in saving the world. A woman named Alana Jobson pays to take on the Jackpot codename, and Sara willingly gives it to her and is eager to return to her normal life. However, Alana is a normal human being, who is using enhancement drugs, including Mutant Growth Hormone, to mimic the powers of her predecessor. Alana dies during a mission and Spider-Man convinces Sara to return to life as a superhero. In a tragic turn of events, her husband dies after a pair of villains discover her real identity, and to protect herself and her daughter, she assumes the name Alana Jobson. This is the plotline of the comic book series that Guggeinheim wrote for.
Guggeinheim is still writing the story, so there has been no word on the cast as yet.
Guggenheim is the only person attached to the project as of now and no other member of the crew has been decided.
If you liked this, you'll love these:
'Spider-Man: Into The Spider-Verse'
'Spider-Man: Far From Home'